Beijing Quarkxia Technology

Quark Biosciences, operating in mainland China as Beijing Quarkxia Technology, is a precision medicine company specializing in high-throughput genomic analysis platforms. The company's core technology, the PanelChip Analysis System, utilizes proprietary microfluidic chips to perform multi-gene expression profiling with high sensitivity and speed. This platform is designed to decentralize complex molecular testing, making it accessible for clinical laboratories and hospitals. Quark Biosciences focuses on developing diagnostic solutions for oncology, reproductive health, and infectious diseases, including products like the B-Quark test for breast cancer recurrence. By combining microfluidics, semiconductor manufacturing, and molecular biology, the company provides a robust Lab-on-a-Chip solution for personalized medicine.